Seriously, how about a database tracking researchers connections to industry and specific trials? Done properly, I think we might find ourselves being paid a bit more attention. PDpipeline data and those past trials that just fizzled could be a start, And it could incorporate things that seemed so promising but then simply disappeared such as the atomization technology discussed under Ron's BBB thread or the info on methylene blue from a year or two ago.
Quote:
Originally Posted by rosie
could olanow's conflict of interest as a paid consultant on the cere-120 trial stem from the fact that he is on ceregene's scientific advisory board?
|